ГоловнаArchive of numbers2023Volume 31, issue 2 (115)Changes in the cerebrospinal fluid during the development of hallucinatory disorders in patients with delirium tremens
Title of the article Changes in the cerebrospinal fluid during the development of hallucinatory disorders in patients with delirium tremens
Authors Linskiy Igor
Zadorozhnyi Volodymyr
In the section DIAGNOSTICS AND THERAPY OF MENTAL AND BEHAVIORAL DISORDERS
Year 2023 Issue Volume 31, issue 2 (115) Pages 47-53
Type of article Scientific article Index UDK 616.89-02:547.262:616.832.9-008.8 Index BBK -
Abstract

 The aim of the work was to study in patients with delirium tremens (DT) in the acute period of the disease during the manifestation of hallucinations of the composition of the cerebrospi- nal fluid (CSF) — the clinical parameters of the CSF, the concentration of creatinine and urea in the CSF, as well as the content of non-ionic osmotically active substances in it. The study included 518 men in the acute period of DT. The age of the patients ranged from 20 to 75 years. The patients had both manifestations of “classic” DT (diagnosis code according to ICD-10 F10.4) and signs of different variants of severe DT (F10.43). All patients had manifestations of hallucina- tory syndrome. According to the severity of hallucinatory disorders, 2 groups of observations were formed from patients with DT. Group 1: moderately pronounced hallucinatory syndrome (63 people). This group included patients with DT, in which manifestations of hallucinations were manifested both during direct examination and from their reports. There were short periods of visual hallucinations, in some cases in combination with auditory hallucinations; at the same time, a critical attitude towards them was sometimes partially preserved. Group 2: significantly pronounced hallucinatory syndrome (455 people). In patients of this group, hallucinatory dis- orders were detected during direct examination, there were long periods of pronounced visual hallucinations, often in combination with tactile, olfactory or auditory hallucinations; criticism of the experienced sensations was completely lost. In patients with DT with a significant severity of the hallucinatory syndrome, characteristic changes in the composition of the CSF were found: a relative increase in cytosis by 24 %, a moderate increase in total protein, as well as concentrations of urea and creatinine. The level of glucose in the CSF did not depend on the severity of hallucinations. A relative increase in the level of non-ionic osmotically acti- ve substances in the CSF was noted with a significant severity of the hallucinatory syndrome. Changes in the cellular and biochemical composition of the CSF in patients with DT with a sig- nificant severity of the hallucinatory syndrome may reflect a restructuring of the water-osmotic state in the cranial cavity with the development of cerebral edema.
Key words delirium tremens, hallucinatory syndrome, composition of cerebrospinal fluid, cerebral edema
Access to full text version of the article pdf download
Bibliography
1. Moir AT, Ashcroft GW, Crawford TB, Eccleston D, Guldberg HC. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. Brain. 1970;93(2):357- 68. doi: 10.1093/brain/93.2.357. PMID: 4912291.
 2. Post RM, Kotin J, Goodwin FK, Gordon EK. Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry. 1973 Jan;130(1):67-72. doi: 10.1176/ ajp.130.1.67. PMID: 4682750.
3. Schwieler L, Larsson MK, Skogh E, Kegel ME, Orhan F, Abdelmoaty S, Finn A, Bhat M, Samuelsson M, Lundberg K, Dahl ML, Sellgren C, Schuppe-Koistinen I, Svensson C, Erhardt S, Engberg G. Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for acti- vation of the kynurenine pathway. J Psychiatry Neurosci. 2015 Mar;40(2):126-33. doi: 10.1503/jpn.140126. PMID: 25455350; PMCID: PMC4354818.
4. Barker SA. N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function. Front Neurosci. 2018 Aug 6;12:536. doi: 10.3389/fnins.2018.00536. PMID: 30127713; PMCID: PMC6088236.
5. Lüngen EM, Maier V, Venhoff N, Salzer U, Dersch R, Berger B, Riering AN, Nickel K, Fiebich BL, Süß P, Maier SJ, Egger K, Tebartz van Elst L, Endres D. Systemic Lupus Erythematosus With Isolated Psychiatric Symptoms and Antinuclear Antibody Detection in the Cerebrospinal Fluid. Front Psychiatry. 2019 Apr 25;10:226. doi: 10.3389/fpsyt.2019.00226. PMID: 31105597; PMCID: PMC6494960.
6. Endres D, Meixensberger S, Dersch R, Feige B, Stich O, Venhoff N, Matysik M, Maier SJ, Michel M, Runge K, Nickel K, Urbach H, Domschke K, Prüss H, Tebartz van Elst L. Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis. Transl Psychiatry. 2020 Aug 12;10(1):279. doi: 10.1038/s41398- 020-00967-3. PMID: 32782247; PMCID: PMC7419532.
7. Rattay TW, Martin P, Vittore D, Hengel H, Cebi I, Tünnerhoff J, Stefanou MI, Hoffmann JF, von der Ehe K, Klaus J, Vonderschmitt J, Herrmann ML, Bombach P, Al Barazi H, Zeltner L, Richter J, Hesse K, Eckstein KN, Klingberg S, Wildgruber D. Cerebrospinal fluid findings in patients with psychotic symptoms-a retrospec- tive analysis. Sci Rep. 2021 Mar 30;11(1):7169. doi: 10.1038/ s41598-021-86170-w. PMID: 33785807; PMCID: PMC8010098.
8. Grenzer IM, Juhl AL, Teegen B, Fitzner D, Wiltfang J, Hansen N. Psychopathology of psychiatric patients presenting autoantibodies against neuroglial antigens. Front Psychiatry. 2022 Nov 10;13:945549. doi: 10.3389/fpsyt.2022.945549. PMID: 36440415; PMCID: PMC9685427.
9. Brooks BR, Adams RD. Cerebrospinal fluid acid-base and lactate changes after seizures in unanesthetized man II. Alcohol withdrawal seizures. Neurology. 1975 Oct;25(10):943-8. doi: 10.1212/wnl.25.10.943. PMID: 1237104.
10. Carlen PL, Kapur B, Huszar LA, Lee MA, Moddel G, Singh R, Wilkinson DA. Prolonged cerebrospinal fluid acido- sis in recently abstinent chronic alcoholics. Neurology. 1980 Sep;30(9):956-62. doi: 10.1212/wnl.30.9.956. PMID: 6775249.
11. Banki CM, Vojnik M. Comparative simultaneous mea- surement of cerebrospinal fluid 5-hydroxyindoleacetic acid and blood serotonin levels in delirium tremens and clozapine- induced delirious reaction. J Neurol Neurosurg Psychiatry. 1978 May;41(5):420-4. doi: 10.1136/jnnp.41.5.420. PMID: 660204; PMCID: PMC493048.
12. Likvorologiya / E. M. Czvetanova ; per. s bolg. Kiev : Zdorov’ia, 1986. 370 s. (In Russian).
13. Malakhov V. O., Potapov O. O., Lychko V. S. Osnovy klinichnoi likvorolohii: navchalnyi posibnyk. Sumy : Sumskyi derzhavnyi universytet, 2016. S. 9, 11—18. URI: https://es- suir.sumdu.edu.ua/bitstream-download/123456789/44968/1/ navch_Lychko.pdf. (In Ukrainian).
14. Paraklinichni metody doslidzhennia v psykhiatrii: Metodychni vkazivky dlia pidhotovky likariv-interniv do praktychnykh zaniat / uporiad. H. M. Kozhyna, L. M. Haichuk, K. O. Zelenska. Kharkiv : KhNMU, 2018. 20 s. (In Ukrainian).
15. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci. 2001 Spring;13(2):229-42. doi: 10.1176/jnp.13.2.229. Erratum in: J Neuropsychiatry Clin Neurosci 2001 Summer;13(3):433. PMID: 11449030.
16. Zadorozhnyy V. V. Shkala otsenki dlitelnosti alkogolnogo deliriya. V zb.: Materialy XVIII Ukrainskoi nauk.-prakt. konf. «Dovzhenkivski chytannia». Kharkiv : Pleyada, 2018. S. 51—52. (In Ukrainian).
17. Laboratornyye metody issledovaniya v klinike : sprav- ochnik / pod red. V. V. Menshikova. Moskva : Meditsina, 1987. 368 s. (In Russian).
18. Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, Sellebjerg F; EFNS Task Force. Guidelines on rou- tine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol. 2006 Sep;13(9):913-22. doi: 10.1111/j.1468- 1331.2006.01493.x. PMID: 16930354.
19. Patent na korysnu model № 44632. Sposib diahnostyky rozladiv vodnoho obminu v porozhnyni cherepa u khvorykh na hostru alkoholnu entsefalopatiiu. Avtor: Zadorozhnyi V. V. (UA). Vlasnyk patentu: DU “Instytut nevrolohii, psykhiatrii ta narkolohii NAMN Ukrainy”. Priorytety: podannia zaiavky 27.04. 2009; publikatsiia 12.10.2009. Biul. № 19, 2009. URI: https://iprop-ua.com/inv/pdf/jx79v1lt-pub-description.pdf. (In Ukrainian).
20. Daruši D. J., Raduloviü D. M., Radovanoviü I. D. Cerebral edema in drug addicts. Vojnosanit Pregl. 2014; 71(6): 554–558. DOI: 10.2298/VSP1406554D.
21. Dalby T., Wohl E., Dinsmore M., Unger Z., Chowdhury T., Venkatraghavan L. Pathophysiology of Cerebral Edema — A Comprehensive Review. J. Neuroanaesth. Crit. Care. 2021; 08(03): 163-172. DOI: 10.1055/s-0040-1721165.